G1 Therapeutics Debt to Equity Ratio 2016-2024 | GTHX
Current and historical debt to equity ratio values for G1 Therapeutics (GTHX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. G1 Therapeutics debt/equity for the three months ending June 30, 2024 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-06-30 |
$0.07B |
$0.03B |
3.01 |
2024-03-31 |
$0.07B |
$0.03B |
2.68 |
2023-12-31 |
$0.09B |
$0.04B |
2.44 |
2023-09-30 |
$0.09B |
$0.04B |
2.09 |
2023-06-30 |
$0.09B |
$0.06B |
1.57 |
2023-03-31 |
$0.12B |
$0.05B |
2.60 |
2022-12-31 |
$0.12B |
$0.07B |
1.73 |
2022-09-30 |
$0.12B |
$0.05B |
2.62 |
2022-06-30 |
$0.12B |
$0.07B |
1.82 |
2022-03-31 |
$0.12B |
$0.10B |
1.18 |
2021-12-31 |
$0.11B |
$0.14B |
0.77 |
2021-09-30 |
$0.07B |
$0.18B |
0.37 |
2021-06-30 |
$0.06B |
$0.21B |
0.30 |
2021-03-31 |
$0.06B |
$0.25B |
0.26 |
2020-12-31 |
$0.05B |
$0.18B |
0.29 |
2020-09-30 |
$0.06B |
$0.20B |
0.31 |
2020-06-30 |
$0.05B |
$0.20B |
0.24 |
2020-03-31 |
$0.03B |
$0.23B |
0.12 |
2019-12-31 |
$0.03B |
$0.26B |
0.12 |
2019-09-30 |
$0.03B |
$0.29B |
0.11 |
2019-06-30 |
$0.02B |
$0.31B |
0.06 |
2019-03-31 |
$0.01B |
$0.34B |
0.04 |
2018-12-31 |
$0.01B |
$0.36B |
0.04 |
2018-09-30 |
$0.01B |
$0.38B |
0.04 |
2018-06-30 |
$0.01B |
$0.18B |
0.08 |
2018-03-31 |
$0.01B |
$0.18B |
0.07 |
2017-12-31 |
$0.01B |
$0.09B |
0.13 |
2017-09-30 |
$0.01B |
$0.11B |
0.10 |
2017-06-30 |
$0.01B |
$0.12B |
0.08 |
2017-03-31 |
$0.00B |
$0.00B |
0.00 |
2016-12-31 |
$0.00B |
|
0.00 |
2016-09-30 |
$0.00B |
$0.00B |
0.00 |
2016-06-30 |
$0.00B |
$0.00B |
0.00 |
2015-12-31 |
$0.00B |
$0.00B |
0.00 |